Atherothrombosis in clinical practice [[electronic resource] /] / edited by Deepak L. Bhatt |
Pubbl/distr/stampa | Oxford ; ; New York, : Oxford University Press, c2013 |
Descrizione fisica | 1 online resource (177 p.) |
Disciplina | 616.1/36 |
Altri autori (Persone) | BhattDeepak L |
Collana | Oxford American cardiology library |
Soggetto topico |
Atherosclerosis
Coronary heart disease |
Soggetto genere / forma | Electronic books. |
ISBN | 0-19-997676-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cover; Contents; Preface; Contributors; 1. Atherothrombosis; 2. Coronary Artery Disease; 3. Valvular Heart Disease; 4. Cerebrovascular Disease: Ischemic Syndromes Due to Atherothrombosis; 5. Atrial Fibrillation; 6. Peripheral Artery Disease; 7. Lipid-Modifying Therapy; 8. Antithrombotic Therapy; 9. Treatment of Primary Hypertension; 10. Therapy for Type 2 Diabetes; Index; A; B; C; D; E; F; G; H; I; L; M; N; O; P; R; S; T; U; V; W |
Record Nr. | UNINA-9910452960003321 |
Oxford ; ; New York, : Oxford University Press, c2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Atherothrombosis in clinical practice [[electronic resource] /] / edited by Deepak L. Bhatt |
Pubbl/distr/stampa | Oxford ; ; New York, : Oxford University Press, c2013 |
Descrizione fisica | 1 online resource (177 p.) |
Disciplina | 616.1/36 |
Altri autori (Persone) | BhattDeepak L |
Collana | Oxford American cardiology library |
Soggetto topico |
Atherosclerosis
Coronary heart disease |
ISBN | 0-19-997676-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cover; Contents; Preface; Contributors; 1. Atherothrombosis; 2. Coronary Artery Disease; 3. Valvular Heart Disease; 4. Cerebrovascular Disease: Ischemic Syndromes Due to Atherothrombosis; 5. Atrial Fibrillation; 6. Peripheral Artery Disease; 7. Lipid-Modifying Therapy; 8. Antithrombotic Therapy; 9. Treatment of Primary Hypertension; 10. Therapy for Type 2 Diabetes; Index; A; B; C; D; E; F; G; H; I; L; M; N; O; P; R; S; T; U; V; W |
Record Nr. | UNINA-9910779856603321 |
Oxford ; ; New York, : Oxford University Press, c2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Atherothrombosis in clinical practice / / edited by Deepak L. Bhatt |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Oxford ; ; New York, : Oxford University Press, c2013 |
Descrizione fisica | 1 online resource (177 p.) |
Disciplina | 616.1/36 |
Altri autori (Persone) | BhattDeepak L |
Collana | Oxford American cardiology library |
Soggetto topico |
Atherosclerosis
Coronary heart disease |
ISBN | 0-19-997676-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cover; Contents; Preface; Contributors; 1. Atherothrombosis; 2. Coronary Artery Disease; 3. Valvular Heart Disease; 4. Cerebrovascular Disease: Ischemic Syndromes Due to Atherothrombosis; 5. Atrial Fibrillation; 6. Peripheral Artery Disease; 7. Lipid-Modifying Therapy; 8. Antithrombotic Therapy; 9. Treatment of Primary Hypertension; 10. Therapy for Type 2 Diabetes; Index; A; B; C; D; E; F; G; H; I; L; M; N; O; P; R; S; T; U; V; W |
Record Nr. | UNINA-9910821095103321 |
Oxford ; ; New York, : Oxford University Press, c2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cardiovascular clinical trials [[electronic resource] ] : putting the evidence into practice / / edited by Marcus Flather, Deepak L. Bhatt, Tobias Geisler |
Pubbl/distr/stampa | Chichester, West Sussex, : Wiley-Blackwell, 2012 |
Descrizione fisica | 1 online resource (413 p.) |
Disciplina | 616.100724 |
Altri autori (Persone) |
FlatherM
BhattDeepak L GeislerTobias |
Soggetto topico |
Cardiovascular system - Diseases - Treatment
Cardiology, Experimental |
ISBN |
1-283-60427-2
1-118-39937-4 9786613916723 1-118-39935-8 1-118-39934-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Copyright page; Contents; List of Contributors; Preface; List of Abbreviations; CHAPTER 1: Introduction to randomized clinical trials in cardiovascular disease; What is a randomized clinical trial?; Concept of randomization; Clinical trial phases; Preclinical studies; Phase 1 clinical trials; Phase 2 clinical trials; Phase 3 clinical trials; Phase 4 clinical trials; Study objective; Study populations; Efficacy variables; Surrogate variables; Control groups; Placebo-controlled trials; Active-control trials; Study design (bias); Methods of randomization; Minimization
Random and systematic errorStudy design issues to overcome systematic bias; Blinding; Study design (samples); Comparisons; Trials to show superiority; Trials to show equivalence or non-inferiority; Trials to show a dose-response relationship; Study protocol; Trial monitoring; Data monitoring; Data analysis sets; Intention-to-treat analysis and data set; Per protocol analysis and on-treatment analysis data sets; Subgroup analysis data sets; Unit of analysis; Missing data; Sensitivity analysis; Analysis methods; Demographic and other baseline characteristics Measurements of treatment complianceAnalysis of efficacy; Distribution of data; Statistical analysis of clinical trials (elementary concepts); Adjustments for covariates; Time to event ("survival") analysis; Sample size and power; Safety evaluation; Subsets and more; Types of significance; Statistical significance; Practical or "clinical" significance; How have trials contributed to medical care?; Clinical trials for treatment of high blood pressure (see also Chapter 12); Clinical trials of atherosclerosis, lipid lowering, and statins (see also Chapter 12) Clinical trials of acute myocardial infarction, coronary thrombosis, aspirin, and fibrinolysis (see also Chapter 4)Conducting reliable trials: issues of size and simplicity; Costs, cost-effectiveness, and health economics; Practical issues: managing a trial, funding, and regulation; What does the future hold?; References; CHAPTER 2: Publishing results of clinical trials and reviewing papers for publication; General considerations; Authorship; Title; Manuscript structure; Abstract; Introduction; Methods; Results, tables, and figures; Discussion; Database searches; References Reviewing a submitted article for a journalIntegrity of the data and novelty of the results; Generalizability; Appropriateness of the study design; Scientific value of hypothesis and validity study results; Adequateness of methods; Ethical issues, plagiarism, and publication fraud; Language style, formatting, and presentation of data; Adequateness of citation; Recommendation to accept or decline the manuscript; References; CHAPTER 3: Management of chronic coronary artery disease; Introduction; Definition and classification; Pathophysiology; Medical management of myocardial ischemia Lifestyle changes |
Record Nr. | UNINA-9910141393203321 |
Chichester, West Sussex, : Wiley-Blackwell, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cardiovascular clinical trials : putting the evidence into practice / / edited by Marcus Flather, Deepak L. Bhatt, Tobias Geisler |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Chichester, West Sussex, : Wiley-Blackwell, 2012 |
Descrizione fisica | 1 online resource (413 p.) |
Disciplina | 616.100724 |
Altri autori (Persone) |
FlatherM
BhattDeepak L GeislerTobias |
Soggetto topico |
Cardiovascular system - Diseases - Treatment
Cardiology, Experimental |
ISBN |
1-283-60427-2
1-118-39937-4 9786613916723 1-118-39935-8 1-118-39934-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Copyright page; Contents; List of Contributors; Preface; List of Abbreviations; CHAPTER 1: Introduction to randomized clinical trials in cardiovascular disease; What is a randomized clinical trial?; Concept of randomization; Clinical trial phases; Preclinical studies; Phase 1 clinical trials; Phase 2 clinical trials; Phase 3 clinical trials; Phase 4 clinical trials; Study objective; Study populations; Efficacy variables; Surrogate variables; Control groups; Placebo-controlled trials; Active-control trials; Study design (bias); Methods of randomization; Minimization
Random and systematic errorStudy design issues to overcome systematic bias; Blinding; Study design (samples); Comparisons; Trials to show superiority; Trials to show equivalence or non-inferiority; Trials to show a dose-response relationship; Study protocol; Trial monitoring; Data monitoring; Data analysis sets; Intention-to-treat analysis and data set; Per protocol analysis and on-treatment analysis data sets; Subgroup analysis data sets; Unit of analysis; Missing data; Sensitivity analysis; Analysis methods; Demographic and other baseline characteristics Measurements of treatment complianceAnalysis of efficacy; Distribution of data; Statistical analysis of clinical trials (elementary concepts); Adjustments for covariates; Time to event ("survival") analysis; Sample size and power; Safety evaluation; Subsets and more; Types of significance; Statistical significance; Practical or "clinical" significance; How have trials contributed to medical care?; Clinical trials for treatment of high blood pressure (see also Chapter 12); Clinical trials of atherosclerosis, lipid lowering, and statins (see also Chapter 12) Clinical trials of acute myocardial infarction, coronary thrombosis, aspirin, and fibrinolysis (see also Chapter 4)Conducting reliable trials: issues of size and simplicity; Costs, cost-effectiveness, and health economics; Practical issues: managing a trial, funding, and regulation; What does the future hold?; References; CHAPTER 2: Publishing results of clinical trials and reviewing papers for publication; General considerations; Authorship; Title; Manuscript structure; Abstract; Introduction; Methods; Results, tables, and figures; Discussion; Database searches; References Reviewing a submitted article for a journalIntegrity of the data and novelty of the results; Generalizability; Appropriateness of the study design; Scientific value of hypothesis and validity study results; Adequateness of methods; Ethical issues, plagiarism, and publication fraud; Language style, formatting, and presentation of data; Adequateness of citation; Recommendation to accept or decline the manuscript; References; CHAPTER 3: Management of chronic coronary artery disease; Introduction; Definition and classification; Pathophysiology; Medical management of myocardial ischemia Lifestyle changes |
Record Nr. | UNINA-9910828067003321 |
Chichester, West Sussex, : Wiley-Blackwell, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Platelets in cardiovascular disease [[electronic resource] /] / editor, Deepak L. Bhatt |
Pubbl/distr/stampa | London, : Imperial College Press, 2008 |
Descrizione fisica | xv, 218 p. : ill |
Disciplina | 615/.71 |
Altri autori (Persone) | BhattDeepak L |
Soggetto topico |
Cardiovascular agents
Blood platelets Cardiovascular system - Diseases |
Soggetto genere / forma | Electronic books. |
ISBN |
1-281-86767-5
9786611867676 1-86094-852-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1. Platelet biology: the role of platelets in hemostasis, thrombosis and inflammation / Richard C. Becker -- 2. Thromboxane antagonists / Brian R. Dulin and Steven R. Steinhubl -- 3. Glycoprotein IIb/IIIa inhibitors / Sam J. Lehman, Derek P. Chew and Harvey D. White -- 4. ADP receptor antagonists / Juhana Karha and Christopher P. Cannon -- 5. Monitoring antiplatelet therapy / Paul Harrison and Alan D. Michelson -- 6. Platelet genomics / Brian K. Jefferson, Kandice Kottke-Marchant and Eric J. Topol -- 7. Future strategies for the development of antiplatelet drugs / Robert A. Harrington. |
Record Nr. | UNINA-9910453550003321 |
London, : Imperial College Press, 2008 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Platelets in cardiovascular disease [[electronic resource] /] / editor, Deepak L. Bhatt |
Pubbl/distr/stampa | London, : Imperial College Press, 2008 |
Descrizione fisica | xv, 218 p. : ill |
Disciplina | 615/.71 |
Altri autori (Persone) | BhattDeepak L |
Soggetto topico |
Cardiovascular agents
Blood platelets Cardiovascular system - Diseases |
ISBN |
1-281-86767-5
9786611867676 1-86094-852-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1. Platelet biology: the role of platelets in hemostasis, thrombosis and inflammation / Richard C. Becker -- 2. Thromboxane antagonists / Brian R. Dulin and Steven R. Steinhubl -- 3. Glycoprotein IIb/IIIa inhibitors / Sam J. Lehman, Derek P. Chew and Harvey D. White -- 4. ADP receptor antagonists / Juhana Karha and Christopher P. Cannon -- 5. Monitoring antiplatelet therapy / Paul Harrison and Alan D. Michelson -- 6. Platelet genomics / Brian K. Jefferson, Kandice Kottke-Marchant and Eric J. Topol -- 7. Future strategies for the development of antiplatelet drugs / Robert A. Harrington. |
Record Nr. | UNINA-9910782274403321 |
London, : Imperial College Press, 2008 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Platelets in cardiovascular disease / / editor, Deepak L. Bhatt |
Edizione | [1st ed.] |
Pubbl/distr/stampa | London, : Imperial College Press, 2008 |
Descrizione fisica | xv, 218 p. : ill |
Disciplina | 615/.71 |
Altri autori (Persone) | BhattDeepak L |
Soggetto topico |
Cardiovascular agents
Blood platelets Cardiovascular system - Diseases |
ISBN |
1-281-86767-5
9786611867676 1-86094-852-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1. Platelet biology: the role of platelets in hemostasis, thrombosis and inflammation / Richard C. Becker -- 2. Thromboxane antagonists / Brian R. Dulin and Steven R. Steinhubl -- 3. Glycoprotein IIb/IIIa inhibitors / Sam J. Lehman, Derek P. Chew and Harvey D. White -- 4. ADP receptor antagonists / Juhana Karha and Christopher P. Cannon -- 5. Monitoring antiplatelet therapy / Paul Harrison and Alan D. Michelson -- 6. Platelet genomics / Brian K. Jefferson, Kandice Kottke-Marchant and Eric J. Topol -- 7. Future strategies for the development of antiplatelet drugs / Robert A. Harrington. |
Record Nr. | UNINA-9910825818903321 |
London, : Imperial College Press, 2008 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|